Cargando…
Isoquercitrin restrains the proliferation and promotes apoptosis of human osteosarcoma cells by inhibiting the Wnt/β-catenin pathway
Currently, chemotherapeutic drugs are widely used for the treatment of osteosarcoma. However, many of these drugs exhibit shortcomings such as poor efficacy, high toxicity, and tolerance. Isoquercitrin (ISO) is a traditional Chinese medicine that has been proved to exert good therapeutic effects on...
Autores principales: | Wei, Zhun, Zheng, Di, Pi, Wenfeng, Qiu, Yonglong, Xia, Kezhou, Guo, Weichun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846017/ https://www.ncbi.nlm.nih.gov/pubmed/36685044 http://dx.doi.org/10.1016/j.jbo.2023.100468 |
Ejemplares similares
-
Zyxin Inhibits the Proliferation, Migration, and Invasion of Osteosarcoma via Rap1-Mediated Inhibition of the MEK/ERK Signaling Pathway
por: Wei, Zhun, et al.
Publicado: (2023) -
Identification of a novel gene signature with regard to ferroptosis, prognosis prediction, and immune microenvironment in osteosarcoma
por: Zheng, Di, et al.
Publicado: (2022) -
N6-Methyladenosine-Related lncRNAs Are Potential Prognostic Biomarkers and Correlated With Tumor Immune Microenvironment in Osteosarcoma
por: Zheng, Di, et al.
Publicado: (2022) -
TRIM26 inhibited osteosarcoma progression through destabilizing RACK1 and thus inactivation of MEK/ERK signaling
por: Xia, Kezhou, et al.
Publicado: (2023) -
RILP inhibits tumor progression in osteosarcoma via Grb10-mediated inhibition of the PI3K/AKT/mTOR pathway
por: Wei, Zhun, et al.
Publicado: (2023)